Valuation: Krka, d. d.

Market Cap 7.87B 9.08B 7.38B 6.73B 12.66B 867B 12.86B 86.89B 33.92B 434B 34.1B 33.36B 1,447B P/E 2026 *
18.7x
P/E 2027 * 17.9x
Enterprise Value 7.2B 8.31B 6.75B 6.16B 11.58B 793B 11.77B 79.49B 31.03B 397B 31.19B 30.52B 1,324B EV / Sales 2026 *
3.33x
EV / Sales 2027 * 3.13x
Free-Float
74.74%
Yield 2026 *
3.85%
Yield 2027 * 3.94%
1 day-0.19%
1 week-0.19%
1 month-2.08%
3 months+1.76%
6 months+10.43%
Current year+27.83%
1 week 258.5
Extreme 258.5
262
1 month 257
Extreme 257
270
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 100
Extreme 100
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2005
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2005
Director/Board Member 59 01/01/2005
Director/Board Member 73 01/01/2010
Change 5-day change 1-year change 3-year change Capi.($)
-0.19%-0.19%+29.10%+135.91% 9.08B
-0.10%-0.77%+17.58%+70.16% 48.57B
-3.26%-5.31%+53.19%+117.23% 40.99B
-0.60%-0.94%-7.29%+17.35% 12.35B
-2.75%+1.88%+14.81%+76.92% 12.2B
+1.09%+5.03%+22.89%+39.14% 7.41B
+0.52%+2.08%+40.75%-12.45% 7.13B
-0.07%+1.72%+13.39%+190.65% 6.86B
+1.45%+5.76%-25.73%+30.37% 5.92B
+1.61%+5.26%+36.74%+111.25% 4.73B
Average -0.23%+2.02%+19.54%+77.65% 15.52B
Weighted average by Cap. -0.99%+1.22%+25.53%+82.55%

Financials

2026 *2027 *
Net sales 2.16B 2.5B 2.03B 1.85B 3.48B 238B 3.54B 23.88B 9.32B 119B 9.37B 9.17B 398B 2.29B 2.64B 2.15B 1.96B 3.68B 252B 3.74B 25.28B 9.87B 126B 9.92B 9.71B 421B
Net income 427M 492M 400M 365M 686M 46.98B 697M 4.71B 1.84B 23.51B 1.85B 1.81B 78.44B 449M 518M 421M 383M 722M 49.4B 733M 4.95B 1.93B 24.73B 1.94B 1.9B 82.49B
Net Debt -670M -773M -628M -573M -1.08B -73.77B -1.09B -7.4B -2.89B -36.93B -2.9B -2.84B -123B -708M -817M -663M -605M -1.14B -77.93B -1.16B -7.81B -3.05B -39.01B -3.07B -3B -130B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
13/08/26 €260.00 +0.19% 8,094
12/08/26 €259.50 -0.19% 2,359
11/08/26 €260.00 0.00% 2,489
10/08/26 €260.00 -0.19% 5,134
07/08/26 €260.50 +0.19% 5,771
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
260.00EUR
Average target price
245.65EUR
Spread / Average Target
-5.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock